GILEAD SCIENCES, INC. - Significant Ownership

Signature - Title: Andrew D. Dickinson - Executive Vice President and Chief Financial Officer
Location: Foster City, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by GILEAD SCIENCES, INC..

Significant Ownership of GILEAD SCIENCES, INC.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
RCUS	Arcus Biosciences, Inc.	Common Stock, par value $0.0001	35%	$520M		39.7M		GILEAD SCIENCES, INC.	Feb 18, 2025
GLPG	Galapagos NV	Ordinary Shares, no par value	29.9%	$542M		21M		Gilead Sciences, Inc.	Jan 7, 2025
ASMB	Assembly Biosciences, Inc.	Common Stock, par value $0.001	29.9%	$2.08M		2.21M		Gilead Sciences, Inc.	Dec 19, 2024
XLO	Xilio Therapeutics, Inc.	Common Stock, par value $0.0001 per share	19.9%	$8.29M		9.11M		GILEAD SCIENCES INC	Dec 18, 2024
	Kalaris Therapeutics, Inc.	Common Stock, $0.0001 per value	3.9%			723K		GILEAD SCIENCES, INC.	Mar 18, 2025
IKNA	Ikena Oncology, Inc.	Common Stock	3.6%	$2.49M		1.52M		GILEAD SCIENCES INC	Dec 31, 2024

Schedules 13D/G Reported by GILEAD SCIENCES, INC.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed

* An asterisk sign (*) next to the price indicates that the price is likely invalid.